Cited by 673Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchCardiovascular Function and Risk Factors

The DOI matches its Crossref record, with a small difference in title or year; 6 of the 6 references it cites were found in a registry or an index.

Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?

Haffner, Steven M.·1990·JAMA

DOI 10.1001/jama.1990.03440210043030

Open this paper in CoChat — free account

Abstract

Although type II diabetes is associated with both microvascular and macrovascular complications, duration of diabetes and severity of glycemia are strongly associated only with the former. Since prediabetic individuals are hyperinsulinemic, and since hyperinsulinemia may be a cardiovascular risk factor, we hypothesized that prediabetic individuals might have an atherogenic pattern of risk factors even before the onset of clinical diabetes, thereby explaining the relative lack of an association of macrovascular complications with either glycemic severity or disease duration. We documented the cardiovascular risk factor status of 614 initially nondiabetic Mexican Americans who later participated in an 8-year follow-up of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Individuals who were nondiabetic at the time of baseline examination, but who subsequently developed type II diabetes (ie, confirmed prediabetic subjects, n = 43), had higher levels of total and lowdensity lipoprotein cholesterol, triglyceride, fasting glucose and insulin, 2-hour glucose, body mass index, and blood pressure, and lower levels of high-density lipoprotein cholesterol than subjects who remained nondiabetic (n = 571). Most of these differences persisted after adjustment for obesity and/or level of glycemia, but were abolished after adjustment for fasting insulin concentration. When subjects with impaired glucose tolerance at baseline (n = 106) were eliminated, the more atherogenic pattern of cardiovascular risk factors was still evident (and statistically significant) among initially normoglycemic prediabetic subjects. These results indicate that prediabetic subjects have an atherogenic pattern of risk factors (possibly caused by obesity, hyperglycemia, and especially hyperinsulinemia), which may be present for many years and may contribute to the risk of macrovascular disease as much as the duration of clinical diabetes itself. (JAMA. 1990;263:2893-2898)

Integrity signals

Registry

Crossref · 10.1001/jama.1990.03440210043030

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The publisher hasn’t deposited this paper’s reference list.

Sorted by citations

Items 501–600 of 673

Does insulin resistance cause atherosclerosis in the post-prandial period?
Kendrick, M. E. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00319-5 · Cited by 6
Non-obese men with high lipoprotein(a) values– a cardiovascular risk group different from those with the metabolic syndrome?
Lind, H., Nilsson, P. M., Holthuis, N., & Lindholm, L. H. (1994) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519409086525 · Cited by 6
Insulin resistance, hypertension and cellular ion transport systems
Solini, A., & DeFronzo, R. A. (1992) · Acta Diabetologica · doi:10.1007/bf00573488 · Cited by 6
Cardiometabolic risk management in type 2 diabetes and obesity
Taylor, A. M. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0061-7 · Cited by 6
Prandial glucose regulation and cardiovascular disease in Type 2 diabetes
Kuusisto, & Laakso, M. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00006.x · Cited by 6
Prevención primaria de diabetes tipo 2 en Argentina: estudio piloto en la provincia de Buenos Aires
Gagliardino, J. J., Etchegoyen, G. S., Bourgeois, M. J., Fantuzzi, G., García, S., González, L., Elgart, J. F., Ré, M., Ricart, A. O., Ricart, J. P. A., et al. (2016) · Revista Argentina de Endocrinología y Metabolismo · doi:10.1016/j.raem.2016.11.002 · Cited by 6
Type 2 diabetes mellitus in adolescence: Lipid and cardiovascular risk factors
Jones, K. L., & Dewan, A. K. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0073-2 · Cited by 6
Commentary: Cardiovascular risk factors--the next epidemic in Uganda: findings from the population-based HIV/AIDS rural surveillance cohort
Jafar, T. H. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq169 · Cited by 6
Bibliography
&NA; (2003) · Coronary Artery Disease · doi:10.1097/00019501-200306000-00010 · Cited by 6
The Transcultural Diabetes Nutrition Algorithm
Hegazi, R. A. F., Devitt, A. A., & Mechanick, J. I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800093-9.00022-3 · Cited by 5
The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes
Huang, X., Li, S., Yang, M., Xu-quan, F., Li, H., Tong, Y., Liu, Y., Chen, L., Lan, L., Li, L., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.033 · Cited by 5
Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study
van der Heide, F. C. T., Mokhtar, S., Khanna, A., Said, M., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230104 · Cited by 6
Effect of gastric bypass on BMI and lipid metabolism in type 2 diabetes mellitus
Zhang, C., Cai, W., Zhao, H., Zhu, M. J., Cui, J., & Sun, Z. (2020) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2020.1770263 · Cited by 5
Diabetes and Cardiovascular Disease
Hill‐Briggs, F., Naqibuddin, M., & Golden, S. H. (2022) · Springer eBooks · doi:10.1007/978-0-387-85960-6_58 · Cited by 5
A Cardiologist’s Perspective on Cardiometabolic Risk
Plutzky, J. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.10.008 · Cited by 5
Fibrates: old drugs with a new role in type 2 diabetes prevention?
Elkeles, R. S. (2011) · The British Journal of Diabetes · doi:10.1177/1474651410397245 · Cited by 5
Augmented growth response to IGF-1 via increased IRS-1 in Chinese hamster ovary cells expressing kinase-negative insulin receptors
Inoue, S., Fukuda, K., Kudara, T., Igura, T., Inui, Y., Tamura, S., Hanafusa, T., Kawata, S., & Matsuzawa, Y. (1999) · Diabetologia · doi:10.1007/s001250051226 · Cited by 5
Cutaneous microvascular perfusion responses to insulin iontophoresis are differentially affected by insulin resistance after spinal cord injury
Fountaine, M. F. L., Cirnigliaro, C. M., Azarelo, F., Hobson, J. C., Tascione, O. F., Swonger, K. N., Dyson‐Hudson, T. A., & Bauman, W. A. (2017) · Experimental Physiology · doi:10.1113/ep086239 · Cited by 5
Diabetic dyslipidaemia: past, present and future
Betteridge, D. J. (2004) · Practical Diabetes · doi:10.1002/pdi.593 · Cited by 5
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate
Evans, M., McEwan, P. C., Peters, J. R., & Currie, C. J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00340.x · Cited by 5
Epidemiology of macrovascular disease and hypertension in diabetes mellitus
Tuomilehto, J. O., Rastenytė, D., Qiao, Q., Barengo, N. C., & Matz, K. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch69 · Cited by 5
Serum uric acid to HDL-Chol ratio (UHR) is associated with insulin resistance/sensitivity in individuals without diabetes
Rubino, M., Massimino, M., Mancuso, E., Averta, C., Palummo, A., Perticone, M., Succurro, E., Sciacqua, A., Mannino, G. C., & Andreozzi, F. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02576-2 · Cited by 4
Atherogenic lipid parameters in people with normal glucose tolerance: implications from elevated 1-hour post-load plasma glucose
Yang, C., Chai, X., Wang, Y., Li, D., Zhu, D., Liang, K., Wang, J., Yang, Z., Gong, Q., Zhang, J., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02722-8 · Cited by 4
Cardiometabolic risk stratification in pediatric obesity: evaluating the clinical utility of fasting insulin and BMI-SDS
Stenlid, R., Amrani, S. E., Cerenius, S. Y., Aydın, B. K., Manell, H., Mörwald, K., Lischka, J., Gomahr, J., Pixner, T., Ciba, I., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02882-7 · Cited by 5
Prevalence of prediabetes and association with cardiometabolic and renal factors. SIMETAP-PRED study
Arranz-Martínez, E., Ruiz‐García, A., Álvarez, J. C. G., Vicente, T. F., Iturmendi-Martínez, N., & Rivera-Teijido, M. (2022) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2022.06.005 · Cited by 4
How can we identify candidates at highest risk – to screen or not to screen?
Barengo, N. C., & Tuomilehto, J. O. (2016) · Herz · doi:10.1007/s00059-016-4417-5 · Cited by 4
Serum Insulin Is Significantly Related to Components of the Metabolic Syndrome in Japanese Working Men
Kawada, T., Inagaki, H., Wakayama, Y., Li, Q., & Katsumata, M. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00239.x · Cited by 4
Serum glucose control in diabetic patients with cardiovascular disease: Should we be less aggressive?
Mudaliar, S. R. D. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0058-y · Cited by 4
Insulin resistance and vascular disease
Maritz, F. J. (2004) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2004.11073590 · Cited by 4
Reduction of cardiovascular morbidity and mortality in Type 2 diabetes. A rational approach to hypoglycemic therapy
Spallarossa, P., Barsotti, A., Cordera, R., Ghigliotti, G., Maggi, D. C., & Brunelli, C. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345297 · Cited by 4
Lipids, thrombosis and cardiovascular disease in diabetes
Yudkin, J. S. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970031 · Cited by 4
AN AYURVEDIC POLYHERBAL FORMULATION PDBT FOR DYSLIPIDEMIA AND PREVENTION OF CORONARY ARTERY DISEASE (CAD) IN PRE-DIABETIC INDIVIDUALS
Nakanekar, A. V., & Kohli, K. R. (2013) · International Journal of Research in Ayurveda and Pharmacy · doi:10.7897/2277-4343.04515 · Cited by 4
Cardiovascular Disease
Toth, P. P., Shammas, N. W., Dippel, E. J., & Foreman, B. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10027-2 · Cited by 4
Relative and interacting effects of sex, race, and environment upon body cell mass in healthy adults
Kotler, D. P., Thea, D. M., Allison, D. B., Wang, J., Louis, M. S., Keusch, G. T., & Pierson, R. N. (1998) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(1998)10:2 · Cited by 4
Syndrome X
Reaven, G. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_19 · Cited by 4
Diabetes in tomorrow's world: dark clouds do have silver linings
Shepherd, J. (2002) · Diabetes, obesity and metabolism · doi:10.1046/j.1463-1326.2002.00193.x · Cited by 3
Are there specific components of the insulin resistance syndrome that predict the increased atherosclerosis seen in type 2 diabetes mellitus?
Golden, S. H., & Chong, R. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0007-7 · Cited by 4
Analyzing dependence in incidence of diabetes and heart problem using generalized bivariate geometric models with covariates
Islam, M. A., Chowdhury, R. I., & Sultan, K. S. (2016) · Journal of Applied Statistics · doi:10.1080/02664763.2016.1266467 · Cited by 3
IGF Signaling in the Heart in Health and Disease
Adasheva, D. A., & Serebryanaya, D. V. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924080042 · Cited by 3
Diabetic Dyslipidemia and the Heart
Vasudevan, A. R., & Garber, A. J. (2006) · Heart Failure Clinics · doi:10.1016/j.hfc.2005.12.001 · Cited by 3
Assessment of coronary heart diseases in diabetics in al-Madinah al-Munawarah
El‐Bab, M. F., AL-Nozha, Mojadadi, & Mosaad (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s27373 · Cited by 3
Retracted
Blood pathway analyses reveal differences between prediabetic subjects with or without dyslipidaemia. The Cardiovascular Risk in Young Finns Study
Laaksonen, J., Taipale, T., Seppälä, I., Raitoharju, E., Mononen, N., Lyytikäinen, L., Waldenberger, M., Illig, T., Hutri‐Kähönen, N., Rönnemaa, T., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2914 · Cited by 3
The relationship between coronary artery severity and insulin resistance in patients with impaired glucose tolerance and metabolic syndrome
Metwally, Y. G., Sedrak, H. K., & Shaltout, I. F. (2020) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-020-00022-z · Cited by 3
Prevalencia de prediabetes y asociación con factores cardiometabólicos y renales. Estudio SIMETAP-PRED
Arranz-Martínez, E., Ruiz‐García, A., Álvarez, J. C. G., Vicente, T. F., Iturmendi-Martínez, N., & Rivera-Teijido, M. (2022) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.12.002 · Cited by 3
Type 2 Diabetes Mellitus and Dyslipidemia
Cederberg, H., & Laakso, M. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_6 · Cited by 3
Sex differences in HDL ApoC-III in American Indian youth
Blackett, P. R., Khan, S. H., Wang, W., Alaupovic, P., & Lee, E. T. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-18 · Cited by 3
The fats of life in diabetes
Wierzbicki, A. S. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412462042 · Cited by 3
Casual serum triglyceride as a predictor of premature type 2 diabetes mellitus: an 8-year cohort study of middle-aged Japanese workers
Nishikawa, T., Okamura, T., Shima, A., Kawatsu, Y., Sugiyama, D., Kadota, A., Morimoto, A., Tatsumi, Y., Godai, K., & Miyamatsu, N. (2015) · Diabetology International · doi:10.1007/s13340-015-0241-z · Cited by 3
Diabetic complications are associated with high blood pressure for type-2 diabetes patients
Njølstad, I. (2001) · Evidence-based Healthcare · doi:10.1054/ebhc.2000.0366 · Cited by 3
Statin policy and target populations: evidence-based or evidence-biased?
Durrington, P. N. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137223.61901.a9 · Cited by 3
Lipid Lowering Therapy
Smith, D. A. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_4 · Cited by 3
Systemic inhibition of de novo purine biosynthesis prevents weight gain and improves metabolic health by increasing thermogenesis and decreasing food intakePreprint
Myers, J. W., Park, W. Y., Eddie, A. M., Shinde, A. B., Prasad, P., Murphy, A. C., Leonard, M. Z., Pinette, J. A., Rampy, J., Montufar, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.28.620705 · Cited by 3
Hipertensión arterial y dislipemia asociadas a diabetes mellitus. Papel de los PPAR. Enfoque terapéutico
Bertomeu‐González, V., Pernas, D. N., & Bertoméu, V. (2007) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(07)75270-6 · Cited by 1
Abnormal Glucose Tolerance in Prediabetes Patients with Acute Myocardial Infarction: Implications for Therapy
Laichuthai, N., & DeFronzo, R. A. (2021) · Journal of Endocrinological Science · doi:10.29245/2767-5157/2021/1.1115 · Cited by 2
Comparison of plasma lipid profiles and atherogenic indices among hypertensives with or without type 2 diabetes
Olamoyegun, M. A., Ala, O. A., Iwuala, S. O., & Fawale, B. M. (2022) · Sahel Medical Journal · doi:10.4103/smj.smj_37_19 · Cited by 2
Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf
Alessa, T., Alawadi, F., Alkaabi, J., Al-Mamari, A., Al‐Ozairi, E., Alromaihi, D., Elhadd, T. A., Gunaid, A. A., Hassanein, M. M., Jayyousi, A., et al. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s491591 · Cited by 2
Cardiometabolic Plasticity in Response to a Short-Term Diet and Exercise Intervention in Young Hispanic and NonHispanic White Adults
Schmidt, S. L., Hickey, M. S., Koblenz, K. M., Klamer, H., Botero, M. F., Pfaffenbach, K. T., Pagliassotti, M. J., & Melby, C. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016987 · Cited by 2
Type 2 Diabetes and the Metabolic Syndrome
Haffner, S. M. (2004) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/01.hpc.0000137966.55044.37 · Cited by 2
Self-citation
Dislipemia diabética, síndrome metabólico y riesgo cardiovascular
Otero, I. G., & González‐Juanatey, J. R. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)75325-0 · Cited by 2
Diabetes and Atherosclerosis: Mechanisms and Management
Horvit, P. K., & Garber, A. J. (1998) · Endocrine Practice · doi:10.4158/ep.4.2.112 · Cited by 2
Dyslipidaemia in diabetes—an approach to therapeutic intervention
Raal, F. J. (2006) · South African Family Practice · doi:10.1080/20786204.2006.10873484 · Cited by 2
Review: Imaging to assess effect of medical therapy in patients with diabetes mellitus
Raggi, P., & Bellasi, A. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070040401 · Cited by 2
Apolipoprotein levels in type 2 diabetes mellitus patients
Garg, G., Agarwal, P. K., Manocha, A., & Garg, A. (2016) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2016.03.012 · Cited by 2
Fish and Fish Oil for Cardiovascular Disease in Diabetes
Ward, R. E., & Hintze, K. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802844-5.00020-8 · Cited by 2
Cardiac Rehabilitation
Whiteson, J. H., & Einarsson, G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0884-4.10033-3 · Cited by 3
Insulin resistance syndrome: a potent culprit in cardiovascular disease
Coulston, A. M., & Peragallo‐Dittko, V. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2003.12.011 · Cited by 2
Diabetes Mellitus
Hsu, W. C., Aiello, L. M., Barnett, D. M., & Cavallerano, J. D. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50324-6 · Cited by 2
Long‐Term Implications for the Mother with Hyperglycemia in Pregnancy
Mestman, J. H. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch24 · Cited by 2
Nutritional Management for Type 2 Diabetes
Coulston, A. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012193155-1/50031-3 · Cited by 2
A 47 year old diabetic male with dyspnoea: ‘The ticking time bomb’
Song, S., Lewis, M. J., Campbell, I., & Nawroz, I. (1998) · Practical Diabetes · doi:10.1002/pdi.1960150611 · Cited by 2
Cardiovascular Disease and Insulin Resistance
Ajjan, R., & Grant, P. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_138 · Cited by 2
The safety and effectiveness of human growth hormone using pharmacological dosing
Slyper, A. H. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90234-1 · Cited by 2
Hypertension management in patients with diabetic nephropathy
McCall, A. L. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0021-9 · Cited by 2
What Have We Learned from the Number of Clinical Trials?
Lindström, J. (2013) · Wiley eBooks · doi:10.1002/9781118661321.ch1 · Cited by 2
¿Debe equipararse el abordaje preventivo del riesgo cardiovascular en la diabetes mellitus tipo 2 a la prevención secundaria? (II)
Trillo, J. M. M. (2005) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(05)75193-8 · Cited by 2
Therapy for Type 2 Diabetes
Leinung, M. C., Bell, D. S. H., Fonseca, V. A., Kendall, D. M., Sobel, B. E., & Service, F. J. (2003) · Endocrine Practice · doi:10.4158/ep.9.6.566 · Cited by 2
Introduction
Reaven, G. M. (1993) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610090502 · Cited by 2
The correlation between HOMA-IR and cardiometabolic risk index among different metabolic adults: a cross-sectional study
Lu, Q., Chen, B., Li, A., Liang, Q., Yao, J., Tao, Y., Dai, F., Hu, X., Lu, J., Liu, Y., et al. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02332-y · Cited by 5
Relationship Between the Systemic Immune‐Inflammation Index and Non‐Dipper Blood Pressure Status in Normotensive Patients With Prediabetes
Turan, E., Turan, Y., Yolcu, M., KIZILKAYA, H., Sivri, S., & Karagöz, A. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70189 · Cited by 1
Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes
Abusnana, S., Sabbour, H. M., Afandi, B. O., Farghaly, M., Farooqi, M. H., Hafidh, K., Hassanein, M. M., Jabbar, A., Shehab, A., Kalimat, R., et al. (2026) · Vascular Health and Risk Management · doi:10.2147/vhrm.s579970 · Cited by 1
Intestinal Disaccharidase Activity and Uptake of Glucose from Sucrose
Halschou-Jensen, K., Bukhave, K., & Rikardt, J. (2012) · InTech eBooks · doi:10.5772/53099 · Cited by 1
Interleukin-18 in Metabolic Syndrome and Diabetes
Trøseid, M., Arnesen, H., & Seljeflot, I. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385083-6.00020-6 · Cited by 1
Performance of four risk scores for predicting insulin resistance in Thai adults
Srisung, W., Saprungruang, A., & Jiamjarasrangsi, W. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0066-2 · Cited by 1
The metabolic syndrome: the whole is more than the sum of its parts
Waine, C. (2005) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2005.04.007 · Cited by 1
Serum insulin is significantly related to components of the metabolic syndrome in Japanese working women
Kawada, T., Otsuka, T., Inagaki, H., Wakayama, Y., Li, Q., Li, Y., & Katsumata, M. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.12.005 · Cited by 1
Diabetes mellitus tipo 2. Manifestaciones clínicas y seguimiento. Referencia a la medicina especializada
Pombo, J. L. H., & Sánchez-Vilar, O. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70146-0 · Cited by 1
Impacto de la prediabetes y el sexo en el riesgo cardiovascular asociado al síndrome metabólico
Navarro, A. M. G., Ledo, M. D. P. R., Arenal, J. M. C., López, P. J. T., del Corro, M. R., & Garzón, L. M. (2009) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2009.04.003 · Cited by 1
Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial
Chiasson, J., Laakso, M., & Hanefeld, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3314-9_10 · Cited by 1
Obésité et syndrome métabolique : une épidémie pour le nouveau siècle
Bordier, L., Crémades, S., Dupuy, O., Mayaudon, H., & Bauduceau, B. (2009) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32468-9 · Cited by 1
Special Patient Populations: Diabetes and Metabolic Syndrome
Kurra, S., Chahil, T. J., & Ginsberg, H. N. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50041-x · Cited by 1
A Study of Changes in Lipid Profile among Pre-diabetics and Diabetics in Population of Lucknow
Mc, S., Nagar, A. C., Gautam, A., & Srivastava, R. (2019) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2019.6.12.37 · Cited by 1
Evaluation of the relationship between the one-hour plasma glucose concentration and beta-cell functions and cardiometabolic parameters during oral glucose tolerance test in obese children and adolescents
Mengen, E., & Uçaktürk, S. A. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0016 · Cited by 3
Relationship between Indices of Vascular Function and Presence of Overt Cardiovascular Disease among Persons with Poorly Controlled Type 2 Diabetes
Antoniou, S., Naka, K. Κ., Papadakis, M., Bechlioulis, A., Makriyiannis, D., Tsatsoulis, A. A., Michalis, L. K., & Tigas, S. K. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd8120185 · Cited by 1
The Effect of Atherosclerotic Load on Transmetatarsal Amputation Failure in Patients with Diabetic Foot
Çildağ, M. B., Şahin, T., Ceylan, E., & Şavk, Ş. Ö. (2022) · Meandros Medical And Dental Journal · doi:10.4274/meandros.galenos.2022.68815 · Cited by 1
Special Patient Populations
Reyes‐Soffer, G., & Ginsberg, H. N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00035-9 · Cited by 1
Factors Associated With Type 2 Diabetes in Older Japanese With Similar Genetic Risk Scores: The Bunkyo Health Study
Bui, T. H., Kaga, H., Kakehi, S., Someya, Y., Tabata, H., Yoshizawa, Y., Naito, H., Tajima, T., Ito, N., Kadowaki, S., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf019 · Cited by 1
Pathophysiologie der Atherosklerose bei Diabetes mellitus
Marx, N. (2005) · Der Diabetologe · doi:10.1007/s11428-005-0014-6 · Cited by 1
Pathophysiologie der Arteriosklerose bei Diabetes mellitus
Marx, N. (2006) · Clinical Research in Cardiology Supplements · doi:10.1007/s11789-006-0004-2 · Cited by 1
Increased CVD Risk in Young Adults With Elevated Non–HDL-C
Miller, M. J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.048 · Cited by 1
Alteration on MMP-2 Levels in Women Diabetes Patients in Basrah
Jasim, F. A., Ameer, M., & Hayder, A.-Z. (2019) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1294/6/062005 · Cited by 1

Authors: Haffner, S. M.
Corresponding author: Haffner, Steven M.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1990-06-06
Volume: 263
Issue: 21
Pages: 2893
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1990.03440210043030
OpenAlex: W4297681290
Cited by: 668
References: 0
Citations by year: 2026: 3 · 2025: 9 · 2024: 14 · 2023: 9 · 2022: 18 · 2021: 12 · 2020: 23 · 2019: 15 · 2018: 16 · 2017: 14 · 2016: 17 · 2015: 25 · 2014: 21 · 2013: 16 · 2012: 22
FWCI: 6.93
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: prediabetes, type 2 diabetes, cardiovascular risk factors, hyperinsulinemia, atherogenic lipid profile, impaired glucose tolerance, macrovascular complications, Mexican Americans, San Antonio Heart Study, fasting insulin, obesity, disease duration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Risk Factors in Confirmed Prediabetic Individuals: Does the Clock for Coronary Heart Disease Start Ticking Before the Onset of Clinical Diabetes?

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks